A Non-Lethal Traumatic/Hemorrhagic Insult Strongly Modulates the Compartment-Specific PAI-1 Response in the Subsequent Polymicrobial Sepsis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Raeven, Pierre ^a   Salibasic, Alma ^a   Drechsler, Susanne ^a   Weixelbaumer, Katrin Maria ^a   Jafarmadar, Mohammad ^a   van Griensven, Martijn ^a,b   Bahrami, Soheyl ^a   Osuchowski, Marcin Filip ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM INJURY; FEMALE; FOLLOW UP; GENE EXPRESSION; HEART; HISTOPATHOLOGY; LIVER; LIVER DYSFUNCTION; MORTALITY; MOUSE; NONHUMAN; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SEPSIS; SURVIVOR;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; FEMALE; HEMORRHAGE; MICE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; SEPSIS; WOUNDS AND INJURIES;

EID: 84873677876     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055467     Document Type: Article

References (61)

1. Peden M, McGee K, and Krug E (2000) Injury: A Leading Cause of the Global Burden of Disease. Geneva: World Health Organization.
2. Martin GS, Mannino DM, Eaton S, Moss M, (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
3. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, et al. (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34: 344-353.
4. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, et al. (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302: 2323-2329.
5. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, et al. (1995) Epidemiology of trauma deaths: a reassessment. J Trauma 38: 185-193.
6. Brattstrom O, Granath F, Rossi P, Oldner A, (2010) Early predictors of morbidity and mortality in trauma patients treated in the intensive care unit. Acta Anaesthesiol Scand 54: 1007-1017.
7. Osborn TM, Tracy JK, Dunne JR, Pasquale M, Napolitano LM, (2004) Epidemiology of sepsis in patients with traumatic injury. Crit Care Med 32: 2234-2240.
8. Redl H, Nikolai A, Kneidinger R, Schlag G (1993) Endothelial and leukocyte activation in experimental polytrauma and sepsis. Behring Inst Mitt 218-228.
9. Delvaeye M, Conway EM, (2009) Coagulation and innate immune responses: can we view them separately? Blood 114: 2367-2374.
10. Van der Poll T, de Boer JD, Levi M, (2011) The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis 24: 273-278.
11. Schochl H, Voelckel W, Maegele M, Solomon C, (2012) Trauma-associated hyperfibrinolysis. Hamostaseologie 32: 22-27.
12. Levi M, Van der Poll T, Schultz M, (2012) Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol 34: 167-179.
13. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, et al. (2008) The coagulopathy of trauma: a review of mechanisms. J Trauma 65: 748-754.
14. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG, (2011) The pathogenesis of sepsis. Annu Rev Pathol 6: 19-48.
15. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, et al. (2008) Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 64: 1211-1217.
16. Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, et al. (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4: 90-97.
17. Bagby GJ, Spitzer JA, (1980) Lipoprotein lipase in rats sensitized to endotoxin by surgical trauma. J Surg Res 29: 110-115.
18. Mailman D, Self A, Henry M, (1999) Time- and surgery-dependent effects of lipopolysaccharide on gut, cardiovascular and nitric oxide functions. Shock 12: 208-214.
19. Tarlowe MH, Duffy A, Kannan KB, Itagaki K, Lavery RF, et al. (2005) Prospective study of neutrophil chemokine responses in trauma patients at risk for pneumonia. Am J Respir Crit Care Med 171: 753-759.
20. Dellas C, Loskutoff DJ, (2005) Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 93: 631-640.
21. Lijnen HR, (2005) Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 3: 35-45.
22. Kwak SH, Wang XQ, He Q, Fang WF, Mitra S, et al. (2006) Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK-mediated pathway. Thromb Haemost 95: 829-835.
23. Park YJ, Liu G, Lorne EF, Zhao X, Wang J, et al. (2008) PAI-1 inhibits neutrophil efferocytosis. Proc Natl Acad Sci U S A 105: 11784-11789.
24. Lorente JA, Garcia-Frade LJ, Landin L, De PR, Torrado C, et al. (1993) Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103: 1536-1542.
25. Raeven P, Feichtinger GA, Weixelbaumer KM, Atzenhofer S, Redl H, et al. (2012) Compartment-specific expression of plasminogen activator inhibitor-1 correlates with severity/outcome of murine polymicrobial sepsis. Thromb Res 129: e238-e245.
26. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, et al. (2007) Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 245: 812-818.
27. Waydhas C, Nast-Kolb D, Gippner-Steppert C, Trupka A, Pfundstein C, et al. (1998) High-dose antithrombin III treatment of severely injured patients: results of a prospective study. J Trauma 45: 931-940.
28. Shapiro NI, Schuetz P, Yano K, Sorasaki M, Parikh SM, et al. (2010) The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 14: R182.
29. Raaphorst J, Johan Groeneveld AB, Bossink AW, Erik HC, (2001) Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients. Thromb Haemost 86: 543-549.
30. Madach K, Aladzsity I, Szilagyi A, Fust G, Gal J, et al. (2010) 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study. Crit Care 14: R79.
31. Garcia-Segarra G, Espinosa G, Tassies D, Oriola J, Aibar J, et al. (2007) Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent. Intensive Care Med 33: 1354-1362.
32. van Veen SQ, Levi M, van Vliet AK, Florquin S, van Gulik TM, et al. (2006) Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis. Crit Care Med 34: 2799-2805.
33. Ganopolsky JG, Castellino FJ, (2004) A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. Am J Pathol 165: 1433-1446.
34. Shapiro NI, Yano K, Sorasaki M, Fischer C, Shih SC, et al. (2009) Skin biopsies demonstrate site-specific endothelial activation in mouse models of sepsis. J Vasc Res 46: 495-502.
35. Fan J, Kapus A, Li YH, Rizoli S, Marshall JC, et al. (2000) Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol 22: 412-421.
36. Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG, (2004) Humane endpoints in shock research. Shock 21: 17-25.
37. Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, et al. (1999) Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun 67: 6603-6610.
38. Cauvi DM, Song D, Vazquez DE, Hawisher D, Bermudez JA, et al. (2012) Period of irreversible therapeutic intervention during sepsis correlates with phase of innate immune dysfunction. J Biol Chem 287: 19804-19815.
39. Drechsler S, Weixelbaumer K, Raeven P, Jafarmadar M, Khadem A, et al. (2012) Relationship between Age/Gender-induced Survival Changes and the Magnitude of Inflammatory Activation and Organ Dysfunction in Post-Traumatic Sepsis. PLoS One.
40. Osuchowski MF, Connett J, Welch K, Granger J, Remick DG, (2009) Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med 37: 1567-1573.
41. Van Griensven M, Kuzu M, Breddin M, Bottcher F, Krettek C, et al. (2002) Polymicrobial sepsis induces organ changes due to granulocyte adhesion in a murine two hit model of trauma. Exp Toxicol Pathol 54: 203-209.
42. Drechsler S, Weixelbaumer KM, Redl H, Van Griensven M, Bahrami S, et al. (2011) Experimentally approaching the ICU: monitoring outcome-based responses in the two-hit mouse model of posttraumatic sepsis. J Biomed Biotechnol 2011: 357926.
43. Wichterman KA, Baue AE, Chaudry IH, (1980) Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 29: 189-201.
44. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296-327.
45. Osuchowski MF, Welch K, Siddiqui J, Remick DG, (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177: 1967-1974.
46. Weixelbaumer KM, Raeven P, Redl H, Van Griensven M, Bahrami S, et al. (2010) Repetitive low-volume blood sampling method as a feasible monitoring tool in a mouse model of sepsis. Shock 34: 420-426.
47. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
48. Barkhausen T, Hildebrand F, Krettek C, Van Griensven M, (2009) DHEA-dependent and organ-specific regulation of TNF-alpha mRNA expression in a murine polymicrobial sepsis and trauma model. Crit Care 13: R114.
49. Brunnemer U, Zeckey C, Hildebrand F, Frink M, Mommsen P, et al. (2011) Androstenediol exerts salutary effects on chemokine response after trauma-hemorrhage and sepsis in mice. J Orthop Trauma 25: 511-515.
50. Desai KH, Tan CS, Leek JT, Maier RV, Tompkins RG, et al. (2011) Dissecting inflammatory complications in critically injured patients by within-patient gene expression changes: a longitudinal clinical genomics study. PLoS Med 8: e1001093.
51. Bochicchio GV, Napolitano LM, Joshi M, Knorr K, Tracy JK, et al. (2002) Persistent systemic inflammatory response syndrome is predictive of nosocomial infection in trauma. J Trauma 53: 245-250.
52. Roumen RM, Hendriks T, van dV, Nieuwenhuijzen GA, Sauerwein RW, et al. (1993) Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218: 769-776.
53. Claridge JA, Schulman AM, Young JS, (2002) Improved resuscitation minimizes respiratory dysfunction and blunts interleukin-6 and nuclear factor-kappa B activation after traumatic hemorrhage. Crit Care Med 30: 1815-1819.
54. Pfeifer R, Lichte P, Schreiber H, Sellei RM, Dienstknecht T, et al. (2012) Models of hemorrhagic shock: Differences in the physiological and inflammatory response. Cytokine.
55. Yamashita M, Darlington DN, Weeks EJ, Jones RO, Gann DS, (1995) Plasminogen activator inhibitor-1 rises after hemorrhage in rats. Am J Physiol 268: E1065-E1069.
56. Lagoa CE, Vodovotz Y, Stolz DB, Lhuillier F, McCloskey C, et al. (2005) The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock. Hepatology 42: 390-399.
57. Iskander KN, Craciun FL, Stepien DM, Duffy ER, Kim J, et al. (2012) Cecal Ligation and Puncture-Induced Murine Sepsis Does Not Cause Lung Injury*. Crit Care Med.
58. Pralong G, Calandra T, Glauser MP, Schellekens J, Verhoef J, et al. (1989) Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost 61: 459-462.
59. Osuchowski MF, Welch K, Yang H, Siddiqui J, Remick DG, (2007) Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol 179: 623-630.
60. Kurosawa S, Stearns-Kurosawa DJ, Kinasewitz GT, (2008) Soluble thrombomodulin: a sign of bad times. Crit Care Med 36: 985-987.
61. Ikegami K, Suzuki Y, Yukioka T, Matsuda H, Shimazaki S, (1998) Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis/multiple organ dysfunction syndrome after blunt trauma. J Trauma 44: 789-794.